» Articles » PMID: 27846907

Copy Number Analysis by Low Coverage Whole Genome Sequencing Using Ultra Low-input DNA from Formalin-fixed Paraffin Embedded Tumor Tissue

Overview
Journal Genome Med
Publisher Biomed Central
Specialty Genetics
Date 2016 Nov 17
PMID 27846907
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Unlocking clinically translatable genomic information, including copy number alterations (CNA), from formalin-fixed paraffin-embedded (FFPE) tissue is challenging due to low yields and degraded DNA. We describe a robust, cost-effective low-coverage whole genome sequencing (LC WGS) method for CNA detection using 5 ng of FFPE-derived DNA. CN profiles using 100 ng or 5 ng input DNA were highly concordant and comparable with molecular inversion probe (MIP) array profiles. LC WGS improved CN profiles of samples that performed poorly using MIP arrays. Our technique enables identification of driver and prognostic CNAs in archival patient samples previously deemed unsuitable for genomic analysis due to DNA limitations.

Citing Articles

Novel liquid biopsy CNV biomarkers in malignant melanoma.

Lukacova E, Hanzlikova Z, Podlesnyi P, Sedlackova T, Szemes T, Grendar M Sci Rep. 2024; 14(1):15786.

PMID: 38982214 PMC: 11233564. DOI: 10.1038/s41598-024-65928-y.


Association between copy number alterations estimated using low-pass whole genome sequencing of formalin-fixed paraffin-embedded prostate tumor tissue and cancer-specific clinical parameters.

Salachan P, Ulhoi B, Borre M, Sorensen K Sci Rep. 2023; 13(1):22445.

PMID: 38105358 PMC: 10725894. DOI: 10.1038/s41598-023-49811-w.


Oral cancer prediction by noninvasive genetic screening.

Poell J, Wils L, Brink A, Dietrich R, Krieg C, Velleuer E Int J Cancer. 2022; 152(2):227-238.

PMID: 36069231 PMC: 9826173. DOI: 10.1002/ijc.34277.


High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC.

Frigola J, Carbonell C, Irazno P, Pardo N, Callejo A, Cedres S J Immunother Cancer. 2022; 10(4).

PMID: 35477861 PMC: 9047699. DOI: 10.1136/jitc-2021-004197.


Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study.

Sabatier R, Vicier C, Garnier S, Guille A, Carbuccia N, Isambert N Mol Oncol. 2022; 16(10):2057-2070.

PMID: 35122700 PMC: 9120890. DOI: 10.1002/1878-0261.13188.


References
1.
Wang Y, Carlton V, Karlin-Neumann G, Sapolsky R, Zhang L, Moorhead M . High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays. BMC Med Genomics. 2009; 2:8. PMC: 2649948. DOI: 10.1186/1755-8794-2-8. View

2.
Scheinin I, Sie D, Bengtsson H, van de Wiel M, Olshen A, van Thuijl H . DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly. Genome Res. 2014; 24(12):2022-32. PMC: 4248318. DOI: 10.1101/gr.175141.114. View

3.
Barker D, Hansen M, Faruqi A, Giannola D, Irsula O, Lasken R . Two methods of whole-genome amplification enable accurate genotyping across a 2320-SNP linkage panel. Genome Res. 2004; 14(5):901-7. PMC: 479118. DOI: 10.1101/gr.1949704. View

4.
Bolognesi C, Forcato C, Buson G, Fontana F, Mangano C, Doffini A . Digital Sorting of Pure Cell Populations Enables Unambiguous Genetic Analysis of Heterogeneous Formalin-Fixed Paraffin-Embedded Tumors by Next Generation Sequencing. Sci Rep. 2016; 6:20944. PMC: 4750064. DOI: 10.1038/srep20944. View

5.
Gorringe K, Hunter S, Pang J, Opeskin K, Hill P, Rowley S . Copy number analysis of ductal carcinoma in situ with and without recurrence. Mod Pathol. 2015; 28(9):1174-84. DOI: 10.1038/modpathol.2015.75. View